Within the past decade, clinical microbiology laboratories experienced revolutionary
changes in the way in which microorganisms are identified, moving away from slow …

Despite the introduction 40 years ago of the inexpensive and effective four-drug (isoniazid,
rifampicin, pyrazinamide and ethambutol) treatment regimen, tuberculosis (TB) continues to …

Rapid progress has been made in the development of new diagnostic assays for
tuberculosis in recent years. New technologies have been developed and assessed, and …

With 1.4 million deaths and 8.7 million new cases in 2011, tuberculosis (TB) remains a
global health care problem and together with HIV and Malaria represents one of the three …

The target for TB elimination is to reduce annual incidence to less than one case per million
population by 2050. Meeting that target requires a 1,000-fold reduction in incidence in little …

Tuberculosis (TB) is a major public health concern worldwide: despite a regular, although
slow, decline in incidence over the last decade, as many as 8.6 million new cases and 1.3 …

Tuberculosis is still one of the most important causes of death worldwide. The 2010 Lancet
tuberculosis series provided a comprehensive overview of global control efforts and …

There is a critical need for improved diagnosis of tuberculosis in children, particularly in
young children with intrathoracic disease as this represents the most common type of …

Tuberculosis (TB) is one of the oldest known human diseases and is transmitted by the
bacteria Mycobacterium tuberculosis (Mtb). TB has a rich history with evidence of TB …

Respiratory tract infections rank second as causes of adult and paediatric morbidity and
mortality worldwide. Respiratory tract infections are caused by many different bacteria …